Yankees prospect Brock Selvidge is set to miss the entire 2026 season following an internal brace procedure on his left elbow. This development, reported by Jonathan Mayo of MLB.com, marks another setback for the promising pitcher.
Drafted by the Yankees in the third round back in 2021, Selvidge, now 23, has yet to secure a spot on the team’s 40-man roster and went unclaimed in the Rule 5 Draft last December. Despite this, he was on the radar for a potential MLB debut in 2026 after showing promise in Double-A during 2025.
There, he posted a 4.68 ERA, with an 18.9% strikeout rate and a 12.2% walk rate. His spring performance was brief but notable, with two scoreless innings and a solid 4-to-1 strikeout-to-walk ratio.
Baseball America had high hopes for Selvidge, ranking him 12th among Yankees prospects heading into the season. They projected him as a potential fourth or fifth starter, boasting a versatile five-pitch mix that includes a solid four-seamer, cutter, and sweeper.
Injuries, unfortunately, are not new for Selvidge. He was slated to appear in the 2024 Futures Game during the MLB All-Star break but had to withdraw due to a pinched nerve in his left biceps.
Before this setback, he had a 3.25 ERA with a 24.6% strikeout rate in his first 12 starts of that year. However, his performance dipped, allowing 17 runs over his final 21 innings, leading to a 7.29 ERA before an injury ended his season in early July.
He underwent surgery in September 2024 and didn't return until late May of the following year.
The 2026 season will mark the third consecutive year that an arm injury has curtailed Selvidge’s playing time. By the time he’s ready to pitch again in 2027, he will have logged just 167 2/3 innings over three years, despite being a regular starter.
Since Selvidge isn’t on the major league roster, he won’t be placed on the 60-day injured list, which means he won’t accrue MLB service time or salary. While he wasn’t expected to be an early-season call-up, his injury now rules out any chance of a mid-season appearance.